DSM


Running down

13/02/20 -"Or perfect timing. The reported 2019 figures were not bad and broadly confirmed our view on the company and the street’s expectations. But they were not glittering like at other companies when ..."

Pages
46
Language
English
Published on
13/02/20
You may also be interested by these reports :
13/02/20
Or perfect timing. The reported 2019 figures were not bad and broadly confirmed our view on the company and the street’s expectations. But they were ...

13/02/20
Clariant reported a conciliatory ending after a challenging and bumpy 2019. But it happened in more than ‘just’ some businesses. With the management ...

12/02/20
Akzo’s FY figures leave certain room for interpretation as we really need to see the annual report. EBITDA is the central metric for our valuation ...

11/02/20
FY19 in line with consensus and slightly above our estimates at the operating level The pace of growth has slowed in Q4 though No major impact ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO